Activating ERBB2/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancer.

Gut 2016 08 28;65(8):1296-305. Epub 2015 Apr 28.

Institute of Pathology, Centre for Integrated Oncology, University Hospital Cologne, Cologne, Germany.

Objective: Microsatellite instability (MSI) is detected in approximately 15% of all colorectal cancers (CRC) and virtually in all cases with Lynch syndrome. The MSI phenotype is caused by dysfunctional mismatch repair (MMR) and leads to accumulation of DNA replication errors. Sporadic MSI CRC often harbours BRAF(V600E); however, no consistent data exist regarding targeted treatment approaches in BRAF(wt) MSI CRC.

Design: Mutations and quantitative MSI were analysed by deep sequencing in 196 formalin fixed paraffin embedded (FFPE) specimens comprising Lynch and Lynch-like CRCs from the German Hereditary Nonpolyposis Colorectal Cancer registry. Functional relevance of recurrent ERBB2/HER2 mutations was investigated in CRC cell lines using reversible and irreversible HER-targeting inhibitors, EGFR-directed antibody cetuximab, HER2-directed antibody trastuzumab and siRNA-mediated ERBB2/HER2 knockdown.

Results: Quantification of nucleotide loss in non-coding mononucleotide repeats distinguished microsatellite status with very high accuracy (area under curve=0.9998) and demonstrated progressive losses with deeper invasion of MMR-deficient colorectal neoplasms (p=0.008). Characterisation of BRAF(wt) MSI CRC revealed hot-spot mutations in well-known oncogenic drivers, including KRAS (38.7%), PIK3CA (36.5%), and ERBB2 (15.0%). L755S and V842I substitutions in ERBB2 were highly recurrent. Functional analyses in ERBB2-mutated MSI CRC cell lines revealed a differential response to HER-targeting compounds and superiority of irreversible pan-HER inhibitors.

Conclusions: We developed a high-throughput deep sequencing approach for concomitant MSI and mutational analyses in FFPE specimens. We provided novel insights into clinically relevant alterations in MSI CRC and a rationale for targeting ERBB2/HER2 mutations in Lynch and Lynch-like CRC.

Download full-text PDF

Source
http://dx.doi.org/10.1136/gutjnl-2014-309026DOI Listing
August 2016
44 Reads

Publication Analysis

Top Keywords

msi crc
16
lynch lynch-like
12
erbb2/her2 mutations
12
msi
9
brafwt msi
8
colorectal cancer
8
crc cell
8
cell lines
8
deep sequencing
8
ffpe specimens
8
crc
7
mutations
5
distinguished microsatellite
4
mononucleotide repeats
4
repeats distinguished
4
non-coding mononucleotide
4
loss non-coding
4
knockdownresults quantification
4
erbb2/her2 knockdownresults
4
quantification nucleotide
4

References

(Supplied by CrossRef)
Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients
Aaltonen et al.
Cancer Res 1994
Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis
Shih et al.
Cancer Res 2001
Microsatellite instability: marker of a mutator phenotype in cancer
Loeb et al.
Cancer Res 1994

Similar Publications